Search
CYNK-001
go.drugbank.com/drugs/DB15722InvestigationalCYNK-001 is a novel allogenic off-the-shelf natural killer (NK) cell therapy originating from human placental CD34+ hematopoietic stem cells and enriched with CD56+/CD3-.
IL15-NK Cell
go.drugbank.com/drugs/DB15725InvestigationalIn particular, incubation with IL-15 allows NK cells to lyse a broad range of fresh and cultured tumor targets that the cell is not normally sensitive to.
Lactobacillus coryniformis K8
go.drugbank.com/drugs/DB15733ExperimentalLactobacillus is a common bacteria found in the gut with Lactobacillus coryniformis K8 being originally isolated from artisan goat cheese.
Retifanlimab
go.drugbank.com/drugs/DB15766ApprovedInvestigationalOn October 2021, Incyte Biosciences withdrew its application for a marketing authorization of retifanlimab for the treatment of squamous carcinoma of the anal canal. … Retifanlimab is a humanized IgG4 kappa monoclonal antibody that binds to the programmed death receptor-1 (PD-1), blocking PD-1 interaction with its ligands, programmed death-ligand 1 (PD-L1) and programmed
Methylisothiazolinone
go.drugbank.com/drugs/DB15884InvestigationalCategories: Compounds used in a research, industrial, or household settingAnethole
go.drugbank.com/drugs/DB15916ApprovedWithdrawnCategories: Compounds used in a research, industrial, or household setting2,3-Dimercapto-1-propanesulfonic acid
go.drugbank.com/drugs/DB15967InvestigationalCategories: Compounds used in a research, industrial, or household settingGarlic oil
go.drugbank.com/drugs/DB15989InvestigationalCategories: Compounds used in a research, industrial, or household settingLevophencynonate
go.drugbank.com/drugs/DB16011InvestigationalLevophencynonate is under investigation in clinical trial NCT02299804 (A Clinical Trial to Evaluate Efficacy and Safety of Levophencynonate Hydrochloride in Patient With Vertigo).